203 related articles for article (PubMed ID: 32439605)
1. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment.
De Vincentis A; Rahmani Z; Muley M; Vespasiani-Gentilucci U; Ruggiero S; Zamani P; Jamialahmadi T; Sahebkar A
Drug Discov Today; 2020 Jul; 25(7):1277-1286. PubMed ID: 32439605
[TBL] [Abstract][Full Text] [Related]
2. The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review.
Shi N; Sun K; Tang H; Mao J
J Clin Lab Anal; 2023 Jun; 37(11-12):e24943. PubMed ID: 37435630
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Han MH; Lee JH; Kim G; Lee E; Lee YR; Jang SY; Lee HW; Chun JM; Han YS; Yoon JS; Kang MK; Lee WK; Kweon YO; Tak WY; Park SY; Park JG; Hur K
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32413995
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis.
Karri K; Waxman DJ
RNA; 2023 Jul; 29(7):977-1006. PubMed ID: 37015806
[TBL] [Abstract][Full Text] [Related]
5. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD).
Tao Q; Xie J; Wu Y; Jin Y
Gastroenterol Hepatol; 2024 May; 47(5):506-516. PubMed ID: 37806343
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers.
Khalifa O; Errafii K; Al-Akl NS; Arredouani A
Dis Markers; 2020; 2020():8822859. PubMed ID: 33133304
[TBL] [Abstract][Full Text] [Related]
9. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease.
Huang R; Duan X; Fan J; Li G; Wang B
Biomed Res Int; 2019; 2019():8690592. PubMed ID: 30931332
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease.
Rohilla S; Awasthi A; Kaur S; Puria R
Life Sci; 2021 Jan; 264():118560. PubMed ID: 33045214
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
Shen X; Guo H; Xu J; Wang J
J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
[TBL] [Abstract][Full Text] [Related]
12. LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Zeng Q; Liu CH; Wu D; Jiang W; Zhang N; Tang H
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979495
[TBL] [Abstract][Full Text] [Related]
13. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions.
Bian EB; Xiong ZG; Li J
J Cell Physiol; 2019 Mar; 234(3):2194-2203. PubMed ID: 30229908
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA in Non-alcoholic fatty liver disease.
Rohilla S; Kaur S; Puria R
Adv Clin Chem; 2022; 110():1-35. PubMed ID: 36210072
[TBL] [Abstract][Full Text] [Related]
15. Characterization of transcriptional modules related to fibrosing-NAFLD progression.
Lou Y; Tian GY; Song Y; Liu YL; Chen YD; Shi JP; Yang J
Sci Rep; 2017 Jul; 7(1):4748. PubMed ID: 28684781
[TBL] [Abstract][Full Text] [Related]
16. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
[TBL] [Abstract][Full Text] [Related]
17. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.
Di Mauro S; Scamporrino A; Petta S; Urbano F; Filippello A; Ragusa M; Di Martino MT; Scionti F; Grimaudo S; Pipitone RM; Privitera G; Di Pino A; Scicali R; Valenti L; Dongiovanni P; Fracanzani A; Rabuazzo AM; Craxì A; Purrello M; Purrello F; Piro S
Liver Int; 2019 Sep; 39(9):1742-1754. PubMed ID: 31169972
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model.
An HJ; Lee YJ; Choe CP; Cho HK; Song DH
Sci Rep; 2021 Nov; 11(1):23005. PubMed ID: 34837012
[TBL] [Abstract][Full Text] [Related]
19. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
Ma TT; Huang C; Ni Y; Yang Y; Li J
Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease.
Sookoian S; Rohr C; Salatino A; Dopazo H; Fernandez Gianotti T; Castaño GO; Pirola CJ
Oncotarget; 2017 Apr; 8(14):22917-22926. PubMed ID: 28206970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
